vidarabine has been researched along with Brain Edema in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bejar, J; Garty-Ofir, M; Kreiniz, N; Polliack, A; Tadmor, T | 1 |
| Hey, SP; Kesselheim, AS | 1 |
| Hawkes, N | 1 |
| Fabiano, AJ; Fenstermaker, RA; Qiu, J; Rigual, D | 1 |
| Thong, YH | 1 |
| Booss, J; Hsiung, GD; Landry, ML | 1 |
| Prange, HW | 1 |
1 review(s) available for vidarabine and Brain Edema
| Article | Year |
|---|---|
[Therapy of herpes simplex encephalitis].
Topics: Acyclovir; Anti-Bacterial Agents; Antiviral Agents; Brain Edema; Bromodeoxyuridine; Dexamethasone; Drug Therapy, Combination; Encephalitis; Ganciclovir; Herpes Simplex; Humans; Immunoglobulins; Interferons; Vidarabine | 1988 |
2 trial(s) available for vidarabine and Brain Edema
| Article | Year |
|---|---|
Trial of novel leukaemia drug is stopped for second time after two more deaths.
Topics: Antineoplastic Agents; Brain Edema; Early Termination of Clinical Trials; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; United States; United States Food and Drug Administration; Vidarabine | 2016 |
Chemotherapy for Herpes Simplex Encephalitis.
Topics: Adult; Age Factors; Biopsy; Brain; Brain Edema; Clinical Trials as Topic; Consciousness; Encephalitis; Herpes Simplex; Humans; Vidarabine | 1981 |
4 other study(ies) available for vidarabine and Brain Edema
| Article | Year |
|---|---|
Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Edema; Cyclophosphamide; Demyelinating Diseases; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Rituximab; Steroids; Vidarabine | 2021 |
The FDA, Juno Therapeutics, and the ethical imperative of transparency.
Topics: Brain Edema; Clinical Trials, Phase II as Topic; Disclosure; Drug Industry; Drugs, Investigational; Humans; Immunotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Safety-Based Drug Withdrawals; United States; United States Food and Drug Administration; Vidarabine | 2016 |
Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Brain Edema; Cerebellar Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Fatal Outcome; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nervous System Diseases; Neurosurgical Procedures; Prednisone; Rituximab; Thalidomide; Treatment Outcome; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia | 2013 |
Duration of vidarabine therapy in biopsy-negative herpes simplex encephalitis.
Topics: Aged; Biopsy; Brain; Brain Edema; Decision Making; Encephalitis; False Negative Reactions; Herpes Simplex; Humans; Male; Time Factors; Vidarabine | 1982 |